Effect of Preoperative Statin Therapy on Patients Undergoing Isolated and Combined Valvular Heart Surgery

Annals of Thoracic Surgery

Volumn 89, Issue 3, 2010, Pages 773-780

  Borger, Michael A ^a   Seeburger, Joerg ^a   Walther, Thomas ^a   Borger, Franka ^a   Rastan, Ardawan ^a   Doenst, Torsten ^a   Mohr, Friedrich W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; FORWARD HEART FAILURE; HEART INFARCTION; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; SURGICAL MORTALITY; SURVIVAL; THERAPY EFFECT;

AGED; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; FEMALE; HEART VALVES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SURVIVAL RATE;

EID: 76849101822     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.12.001     Document Type: Article

References (34)

1. 4S Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
2. Downs J.R., Clearfield M., Weis S., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
3. Ross S.D., Allen I.E., Connelly J.E., et al. Clinical outcomes in statin treatment trials: a meta-analysis. Arch Intern Med 159 (1999) 1793-1802
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
5. Fonarow G.C., Wright R.S., Spencer F.A., et al. Effect of stain use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 96 (2005) 611-616
6. Liao J.K., and Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45 (2005) 89-118
7. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336 (1997) 153-162
8. Liakopoulos O.J., Choi Y.H., Haldenwang P.L., et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 29 (2008) 1548-1559
9. Thielmann M., Neuhauser M., Marr A., et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 134 (2007) 1143-1149
10. Pan W., Pintar T., Anton J., Lee V.V., Vaughn W.K., and Collard C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 Suppl 2 (2004) II-45-II-49
11. Clark L.L., Ikonomidis J.S., Crawford F.A., et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg 131 (2006) 679-685
12. Collard C.D., Body S.C., Shernan S.K., Wang S., and Mangano D.T. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132 (2006) 392-400
13. Lazar H.L. Should all patients receive statins before cardiac surgery?. Are more data necessary?. J Thorac Cardiovasc Surg 131 (2006) 520-522
14. Paraskevas K.I. Applications of statins in cardiothoracic surgery: more than just lipid-lowering. Eur J Cardiothorac Surg 33 (2008) 377-390
15. Fedoruk L.M., Wang H., Conaway M.R., Kron I.L., and Johnston K.C. Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg 85 (2008) 1521-1526
16. Virani S.S., Nambi V., Lee V.V., et al. Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery?. Am J Cardiol 102 (2008) 1235-1239
17. Seeburger J., Borger M.A., Falk V., et al. Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg 34 (2008) 760-765
18. Gummert J.F., Kluge M., Reissmann E.M., Bung J., and Mohr F.W. Einführung eines komplexen medizinischen Dokumentationssystems am Herzzentrum Leipzig. In: Krian A., and Scheld H.H. (Eds). Dokumentationsverfahren in der Herzchirurgie III (1998), Steinkopff, Darmstadt 99-103
19. Akins C.W., Miller D.C., Turina M.I., et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 85 (2008) 1490-1495
20. Knatterud G.L., Rosenberg Y., Campeau L., et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 102 (2000) 157-165
21. Katznelson R., Djaiani G.N., Borger M.A., et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 110 (2009) 67-73
22. Lazar H.L., Bao Y., Zhang Y., and Bernard S.A. Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 125 (2003) 1037-1042
23. Pasceri V., Patti G., Nusca A., et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study. Circulation 110 (2004) 674-678
24. Herrmann J., Lerman A., Baumgart D., et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 106 (2002) 2180-2183
25. Briquori C., Colombo A., Airoldi F., et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J 25 (2004) 1822-1828
26. Ali I.S., and Buth K.J. Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina. Eur J Cardiothorac Surg 27 (2005) 1051-1056
27. Powell B.D., Bybee K.A., Valeti U., et al. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol 99 (2007) 785-789
28. Ferguson T.B., Coombs L.P., and Peterson E.D. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 287 (2002) 2221-2227
29. Mangano D.T., and Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
30. Hansel J., and Simon P. Still without impact on adverse post-operative outcomes: pre-operative statin therapy in patients undergoing cardiac surgery. [letter]. Eur Heart J 29 (2008) 2444
31. Smith S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 113 (2006) 2363-2372
32. Coleman C.I., Lucek D.M., Hammond J., and White C.M. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin 23 (2007) 1783-1790
33. Kjekshus J., Apetrei E., Barrios V., et al., CORONO Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 (2007) 2248-2261
34. Vaughan C.J., and Gotto A.M. Update on statins: 2003. Circulation 110 (2004) 886-892